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ABSTRACT
Background: The adiponectin gene is known to modulate adi-
ponectin concentrations and diabetes mellitus development.
Objective: We assessed whether adiponectin gene variants contrib-
ute to circulating adiponectin, insulin resistance (IR), or cardiovas-
cular disease risk factors.
Design: Nondiabetic subjects [n 902; x  SE age: 42.5 0.53 y;
body mass index (BMI; in kg/m2): 24.7 0.11] were genotyped for
2 single-nucleotide polymorphisms (SNPs), 45T3G and 276G3T.
Results: After adjustment for age, sex, and BMI, subjects with the
G allele for the SNP 276 had significantly higher concentrations of
triacylglycerol and small dense LDL (sdLDL) and smaller LDL
particle size than did T/T subjects. G/G subjects at SNP 276 had
significantly lower plasma adiponectin and higher homeostasis
model assessment (HOMA) of IR and urinary prostaglandin F2
than did T/T subjects. In the SNP 45-276 haplotype test, we also
observed that subjects with the X/X haplotype had significantly
higher plasma adiponectin after adjustment than did TG/TG or TG/X
haplotype subjects. In the highest BMI group (BMI  26), T/T
subjects had lower HOMA-IR (P  0.011) and higher plasma adi-
ponectin (P0.026) at SNP 276 than did G/G or G/T subjects. These
patterns were also seen for adiponectin in haplotype groups. How-
ever, no significant genotype effect for SNP 45T3G was observed.
Conclusions: The 276G3T polymorphism of the adiponectin gene
modulates circulating adiponectin and IR, particularly in obese
states. G allele carriers also have higher oxidative stress, higher
sdLDL concentrations, and smaller LDL particle size. Therefore, the
presence of the G allele in the adiponectin gene at SNP 276 could be
a significant contributor to higher cardiovascular disease risk in
Koreans, independent of common environmental factors. Am J
Clin Nutr 2005;82:760–7.
KEY WORDS Adiponectin, 267G3T, obesity, insulin resis-
tance, cardiovascular disease risk
INTRODUCTION
Circulating concentrations of adiponectin, an adipocyte-
derived protein, correlate inversely with severity of insulin re-
sistance (IR) (1, 2) and with obesity, type 2 diabetes, and cardio-
vascular disease (CVD), all of which are closely related to IR
(3–6). Genetic variability in adiponectin has been inconsistently
associated with low serum adiponectin, IR, diabetes, and CVD
(7, 8).
The adipocyte-, C1Q-, and collagen domain–containing
(ACDC) gene consists of 3 exons and 2 introns and is located on
chromosome 3q27, in the same region where a susceptibility
locus for type 2 diabetes and measures of adiposity have been
mapped (9, 10). Two ACDC single-nucleotide polymorphisms
(SNPs)—ie, the 45T3G in exon 2 and the 276G3T in intron
2—were shown to be associated with type 2 diabetes in a Japa-
nese population (8). In diabetic whites, the 276G3T polymor-
phism was observed to be a predictor of coronary artery disease
(CAD) risk (11). In addition, the SNP 45T3G, either indepen-
dently (12) or as a haplotype together with SNP 276G3T (7),
was strongly associated with obesity and IR syndrome in nondi-
abetic German and Italian whites. However, these associations
were not replicated by Swedish (13) and French (14) investiga-
tors. Therefore, the findings associated with the ACDC locus may
present considerable heterogeneity among populations (15).
Our primary goal was to examine the association between the
2 ACDC polymorphisms and concentrations of circulating adi-
ponectin and IR in a group of healthy Koreans who genetically
and environmentally differ from previously reported studies in
whites. In addition, we examined associations with other, novel
CVD risk factors including visceral fat accumulation, small LDL
particle size, lipid peroxides, and C-reactive protein (CRP),
which may be closely related to low circulating concentrations of
adiponectin and IR.
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SUBJECTS AND METHODS
Study subjects
Nine hundred two nondiabetic subjects were recruited con-
secutively from among2500 participants in a prospective hu-
man genetic study that is supported by a Genome Research De-
velopment Project on Health and Medicine from the Korean
Ministry of Health and Welfare (project no. 00-PJ3-PG6-GN-
01-0001). None of the subjects were taking any medication or
had a diagnosis of coronary vascular disease, diabetes mellitus,
or cancer. Diabetes was ascertained according to the American
Diabetes Association criteria (17) in which diabetes is defined as
a fasting plasma glucose concentration 7 mmol/L or current
treatment with antidiabetic agents.
Written informed consent was obtained from all subjects. The
protocol was approved by the Institutional Review Board of
Yonsei University.
Blood collection
Venous blood specimens were collected in EDTA-treated and
plain tubes after a 12-h fast. The tubes were immediately covered
with aluminum foil and placed on ice until they arrived at the lab-
oratory room (within 1–3 h) and stored at70 °C until analysis.
Genotyping
Genomic DNA was extracted from 5 mL whole blood by using
a commercially available DNA isolation kit (WIZARD Genomic
DNA purification kit; Promega Corp, Madison, WI) according to
the manufacturer’s protocol. We first screened 7 sites of previ-
ously reported ACDC SNPs (11377C3G at proximal pro-
moter, 45T3G at exon 2, 276G3T at intron 2, and H241P,
Y111H, G90S, and R221S at exon 3) in 48 subjects (ratio of
males to females, 1:1; ratio of normal-weight subjects to over-
weight or obese subjects, 1:1) to identify the allele frequency of
each SNP. Each genotyping was performed with assays using
single-primer extension technology (SNP-IT, SNPstream 25K
System; Orchid Biosystems, Princeton, NJ). The DNA frag-
ments were visualized by using ultraviolet illumination and an
image analyzer (AlphaImager 1220; Alpha Innotech Corp, San
Leandro, CA). The pUC19 DNA/Msp I (Hpa II) marker (MBI
Fermentas, Vilnius, Lithuania) served as a control standard.
Anthropometric and blood pressure measurements
Body weight and height were measured in the morning while
the subjects were unclothed and not wearing shoes. Body mass
index (BMI) was calculated as body weight (in kg) divided by
height (in m2). Circumferences of waist and hip were measured
while the subjects were standing after normal expiration, and the
waist-to-hip ratio was also computed. Blood pressure was read
from the left arm by using automatic blood pressure monitor
(TM-2654; A&D, Tokyo, Japan) while subjects remained seated
after a 20-min rest. An average of 3 measurements was recorded
for each subject.
Assessment of food intake and physical activity level
Information about habitual food intake was obtained by using
a 24-h recall method and a semiquantitative food-frequency
questionnaire. We used the former to carry out analyses and the
latter to ascertain whether the data collected by 24-h recall meth-
ods were representative of the usual dietary pattern. Nutrient
intake data were calculated as mean values from a 3-d food record
(2 weekdays and 1 weekend) through the 24-h recall method by
using the database of the computerized Korean food code, based
on food composition tables developed by National Rural Living
Science Institute in Korea (17). Total energy expenditure
(kcal/d) was calculated from activity patterns including basal
metabolic rate, physical activity for 24 h (18), and specific dy-
namic action of food. The basal metabolic rate for each subject
was calculated by using the Harris-Benedict equation (19).
Abdominal fat distribution at the first and fourth lumbar
vertebrae as measured with a computerized tomographic
scanner
Abdominal fat areas were measured by using computerized
tomography scanning with a General Electric (GE) High-Speed
Advantage 9800 scanner (GE, Milwaukee, WI). Two cross-
sectional images were made for each subject: the abdomen at the
levels of the first (L1) and fourth (L4) lumbar vertebra. Each
computed tomographic slice was analyzed for the cross-sectional
area of fat by using a density-control program available in the
standard GE computer software. Parameters for total abdominal
fat density at L1 and L4 were selected between the range of150
and50 Hounsfield units. Total abdominal fat area was divided
into visceral and subcutaneous fat areas to calculate specific fat
areas.
Serum lipid profile
Fasting serum concentrations of total cholesterol and triacyl-
glycerol were measured by using commercially available kits on
a Hitachi 7150 Autoanalyzer (Hitachi Ltd, Tokyo, Japan). After
precipitation of serum chylomicron, LDL, and VLDL by using
dextran sulfate-magnesium, HDL cholesterol left in the super-
natant was measured by an enzymatic method. LDL cholesterol
was estimated indirectly by using the formula of Friedewald et al
(20) for subjects with serum triacylglycerol concentrations
4.52 mol/L (400 mg/mL) and directly measured for subjects
with serum triacylglycerol concentrations4.52 mol/L. Serum
apolipoprotein A-I and B were determined by turbidometry at
340 nm using a specific antiserum (Roche, Basel, Switzerland).
LDL subfraction and LDL particle size
The LDL subfraction was reported previously (21). According
to the method described by Griffin et al (22), total LDL (density:
1.019–1.063 g/mL) was isolated by sequential density gradient ul-
tracentrifugation. Three LDL subfractions (LDL1: 1.025–1.034;
LDL2: d1.034–1.044; and LDL3: d1.044–1.060 g/mL density)
were quantified in fresh plasma by using nonequilibrium density
ultracentrifugation. The percentage areas under the curve for each
individual subfraction were quantified (Data Graphics; Beckman,
High Wycombe, United Kingdom) and corrected for differential
absorption characteristics of total lipoproteins by using extinction
coefficients: 2.63 for LDL1, 2.94 for LDL2, and 1.96 for LDL3. This
coefficient was calculated as a percentage of total LDL (d1.019–
1.063 g/mL) mass and was expressed in milligrams of lipoprotein
per 100 mL plasma. Particle size distribution of LDL (density:
1.019–1.063 g/mL) isolated by sequential floatation ultracentrifu-
gation was examined by using a pore- gradient lipoprotein system
(CBS Scientific, Del Mar, CA) with commercially available, non-
denaturing polyacrylamide slab gels containing a linear gradient of
2–16% acrylamide (Alamo Gels Inc, San Antonio, TX). Standards
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of latexbeads (34nm), thyroglobulin (17nm),apoferritin (12.2nm),
and catalase (10.4 nm) were used to estimate the relative migration
rates of each band. The gels were scanned by using a GS-800 Cal-
ibrated Imaging Densitometer (Bio-Rad Laboratories, Graz, Aus-
tria). LDL particle size was calculated with reference to the relative
migration value of the standards.
Glucose, insulin, free fatty acids, and homeostasis model
assessment of insulin resistance
Fasting glucose was measured by using a glucose oxidase
method and a glucose analyzer (Beckman Instruments, Irvine,
CA). Insulin was measured by using radioimmunoassays with
commercial kits from Immuno Nucleo Corporation (Stillwater,
MN). Free fatty acids (FFAs) were analyzed by using a Hitachi
7150 autoanalyzer (Hitachi Ltd, Tokyo, Japan). IR was calcu-
lated by using HOMA according to the following equation:
IR  [fasting insulin (IU/mL) 
fasting glucose (mmol/L)]/22.5 (1)
Lipid peroxidation
After a 12-h fast and before blood collection, urine was col-
leted into polyethylene bottles containing 1% butylated hydroxy-
toluene. The tubes were immediately covered with aluminum
foil and stored at 70 °C until analysis. We measured 8-epi-
prostaglandin F2 (8-epi-PGF2) by using an enzyme immuno-
assay (BIOXYTECH Urinary 8-epi-PGF2 Assay kit; OXIS In-
ternational Inc, Portland, OR). The resulting color reaction was
read using a Victor2 multilabel counter (Perkin Elmer Life Sci-
ences, Turku, Finland) at 650 nm. Urinary creatinine was mea-
sured by the alkaline picrated (Jaffe) reaction (23), and urinary
8-epi-PGF2 concentrations were expressed as pmol/mmol cre-
atinine. Plasma malondialdehyde was assayed according to the
fluorometric method of Buckingham (24).
Plasma concentration of C-reactive protein and
adiponectin
Plasma CRP was measured by isomg an Express Plus auto-
analyzer (Chiron Diagnostics Co, Walpole, MA) and a commer-
cially available high-sensitivity kit [CRP-Latex (II) X2; Seiken
Laboratories Ltd, Tokyo, Japan] (25). Plasma adiponectin con-
centrations were measured by using an enzyme immunoassay
(Human Adiponectin ELISA kit; B-Bridge International Inc,
Sunnyvale, CA). The resultant color reaction was read at 450 nm
by using a Victor2 multilabel counter.
Statistical analysis
We used SPSS for WINDOWS software (version 11.0; SPSS
Inc, Chicago, IL) for all statistical analyses. Of the screened
ACDC SNPs, we excluded SNPs with missense mutations of
allele frequency 2% and included the others in the analysis. To
examine whether each of the selected SNPs was in Hardy-
Weinberg equilibrium and whether the SNPs were in linkage
disequilibrium, we performed an analysis by using the Executive
SNP Analyzer, version 1.0 (see http://www.istech.info/Sili-
coSNP/index.html?). To evaluate the correlation of the variables,
we used Pearson’s correlation coefficient. We evaluate the in-
fluence of selected SNPs on continuous variables by using a
general linear model and then the Bonferroni test to adjust for
covariates such as age, sex, and BMI, which were highly corre-
lated to IR, and adiponectin concentration. Each variable was
examined for normal distribution, and significantly skewed vari-
ables were log-transformed. For descriptive purposes, mean val-
ues are presented on untransformed and unadjusted variables.
Results are expressed as means SEs. A 2-tailed value of P
0.05 was considered significant.
RESULTS
Detection of SNPs in the ACDC gene
Among the 7 screened polymorphisms in the ACDC gene, we
found 5 rare, nonsynonymous mutations (11391G3A at pro-
moter region and H241P, Y111H, G90S, and R221S at exon 3;
allele frequency 2%) in healthy Koreans. The allele frequen-
cies of these SNPs in the ACDC gene were as follows:
11391G3A (G:A1:0), H241P (A:C1:0), Y111H (T:C
1:0), G90S(G:A  1:0), and R221S (C:A  0.98:0.02). There-
fore, we included SNPs 45T/G and 276G/T in the ACDC gene to
further analysis.
Distribution of 45T/G, 276 G/T, and 45/276 haplotypes
of the ACDC gene
Genotype distributions were in Hardy-Weinberg equilibrium:
49.1% of T/T, 42.8% of T/G, and 8.1% of G/G was at SNP 45, and
50.0% of G/G, 41.7% of G/T, and 8.3% of T/T was at SNP 276.
T is the major allele at position 45 (T frequency  0.705; P 
0.377), and G is the major allele at position 276 (G frequency
0.708; P 0.784); these frequencies are not significantly differ-
ent from those reported in nondiabetic Japanese (T frequency at
position 45 0.714; G frequency at position 276 0.703) (8).
These 2 polymorphisms were in linkage disequilibrium ('D 1;
P  0.0008), and there were estimated 45/276 haplotype fre-
quencies of 17.0% for TG/TG, 23.8% for TG/TT, 24.9% for
TG/GG, 8.3% for TT/TT, 17.8% for TT/GG, and 8.1% for GG/
GG. For subsequent statistical analyses, subjects were divided
into 3 genotype subgroups: homozygous for the TG haplotype
(TG/TG; n  153), heterozygous carriers of the TG haplotype
(TG/X; n 440) and non-TG haplotype carriers (X/X; n 309).
Clinical characteristics and body fat distribution
according to genotype
The clinical characteristics, abdominal fat area, and blood pres-
sure of healthy subjects according to the 45T3G and 276G3T
genotypes are shown in Table 1. There were no significant
genotype-related differences in age, sex distribution, BMI, waist-
to-hip ratio, percentage total body fat, visceral and subcutaneous fat
areas at L1 and L4, or blood pressure. Likewise, there were no
differences among genotypes for cigarette smoking, alcohol con-
sumption, energy intake, or TEE (Table 2). For the 45/276 haplo-
type, we could not observe any significant association with clinical
characteristics and body fat distribution (data not shown).
Serum lipid profiles and small dense LDL according to
genotype
There were no significant genotype-related differences among
SNP 45T3G and 276G3T genotypes with respect to serum
concentrations of HDL, LDL, and total cholesterol and apoli-
poproteins A-I and B (Table 3). Serum triacylglycerol concen-
trations and small dense LDL (LDL3) concentrations (both: Fig-
ure 1) were significantly higher in subjects with the G/G and G/T
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genotypes of SNP 276G3T than in those with T/T after adjust-
ment for possible confounding effects of age, sex, and BMI.
Moreover, LDL2 percentage and LDL particle size were signif-
icantly lower in G carriers of SNP 276G3T than in those with
T/T (Table 3). However, there were no significant genotype ef-
fects of SNP 45 on triacylglycerol, small dense LDL concentra-
tions, or LDL particle size. In addition, mean values of these
variables did not differ significantly between the 45/276 haplo-
type groups (data not shown).
Homeostasis model assessment of insulin resistance and
circulating adiponectin, C-reactive protein, and urinary
prostaglandin F2 concentrations according to genotype
Subjects carrying G/G homozygotes at position 276 had sig-
nificantly lower concentrations of plasma adiponectin and higher
HOMA-IR and urinary excretion of PGF2 than did those with
T/T after adjustment for possible confounding effects of age, sex,
and BMI (Table 4). However, there were no significant genotype
effects of SNP 45T3G on circulating adiponectin concentra-
tions, HOMA-IR, plasma CRP, or urinary excretion of PGF2.
Serum insulin concentrations tended to be higher in the subjects
with the GG genotype for 276G3T, but the difference was not
significant. In addition, serum glucose and plasma CRP concen-
trations did not differ significantly between genotype groups at
SNPs 45 and 276. In the 45/276 haplotype test, subjects with X/X
haplotype had significantly higher concentrations of plasma adi-
ponectin after adjustment for possible confounding effects of
age, sex, and BMI (TG/TG: 6.11 0.30 g/mL; TG/X: 6.06
0.18 g/mL; X/X: 7.16  0.24 g/mL; P  0.007). However,
there were no significant haplotype effects of the 45/276 haplo-
type on HOMA-IR, plasma CRP, and urinary excretion of PGF2
(data not shown).
Relation of adiponectin, triacylglycerol concentrations,
and homeostasis model assessment of insulin resistance to
LDL particle size
Pearson correlation test showed that LDL particle size had
highly significant negative relations with serum fasting triacyl-
glycerol concentrations (r  0.450, P  0.001), HOMA-IR
(r0.215, P 0.001), and LDL3 (r0.513, P 0.001) in
TABLE 1
Age, body fat distribution, and blood pressure according to the genotypes of the ACDC 45T3G and 276G3T genotypes in healthy Koreans1
SNP 45T3G SNP 276G3T
T/T
(n 443)
T/G
(n 386)
G/G
(n 73)
G/G
(n 451)
G/T
(n 376)
T/T
(n 75)
Age (y) 43 12 42 0.83 43 2 43 1 42 1 44 2
Sex (M/F) 156/287 146/240 29/44 168/283 141/235 22/53
BMI (kg/m2) 24.8 0.16 24.7 0.18 24.5 0.37 24.7 0.16 24.6 0.18 24.9 0.40
Waist-hip ratio 0.87 0.00 0.87 0.00 0.88 0.01 0.88 0.00 0.87 0.00 0.87 0.01
Fat (%) 29.6 0.40 29.6 0.44 28.3 0.92 29.6 0.41 29.3 0.43 30.6 0.91
First lumbar vertebra
Visceral fat (cm2) 92.1 2.78 92.1 3.32 97.2 6.02 93.2 2.86 90.9 3.09 96.6 7.36
Subcutaneous fat (cm2) 130.6 3.54 136.6 4.41 123.1 7.59 131.0 3.62 132.5 4.16 141.1 9.35
Fourth lumbar vertebra
Visceral fat (cm2) 79.4 2.11 77.6 2.57 80.4 4.45 80.0 2.22 76.3 2.22 84.2 6.40
Subcutaneous fat (cm2) 188.2 4.24 195.2 4.82 182.1 7.28 188.8 4.11 190.8 4.78 200.2 10.1
Blood pressure (mm Hg)
Systolic 122 1 122 1 119 2 121 1 122 1 122 2
Diastolic 75 1 76 1 76 1 76 1 76 1 75 1
1 SNP, single-nucleotide polymorphism. There were no significant differences between the 45T3G and 276G3T genotypes on the basis of one-way
ANOVA or one-way analysis of covariance by using a general linear model followed by Bonferroni test after adjustment for covariates such as age, sex, and
BMI.
2 x  SE (all such values).
TABLE 2
Cigarette smoking, alcohol consumption, energy intake, and total energy expenditure according to the ACDC 45T3G and 276G3T genotypes in healthy
Koreans1
SNP 45T3G SNP 276G3T
T/T
(n 443)
T/G
(n 386)
G/G
(n 73)
G/G
(n 451)
G/T
(n 376)
T/T
(n 75)
Smoking (cigarettes/d) 15.0 0.71 14.1 0.80 14.9 2.48 16.3 0.79 12.9 0.80 13.8 1.46
Alcohol (g/d) 17.1 1.88 16.6 2.27 22.3 8.44 18.3 2.37 17.5 2.16 15.1 2.23
TEI (kcal/d) 2328 20 2332 23 2345 49 2322 21 2345 22 2315 48
TEE (kcal/d) 2310 19 2341 21 2288 49 2323 19 2322 21 2300 50
TEI:TEE 1.04 0.01 1.03 0.01 1.03 0.01 1.03 0.01 1.04 0.01 1.04 0.01
1 All values are x  SE. SNP, single-nucleotide polymorphism; TEI, total energy intake; TEE, total energy expenditure. There were no significant
differences between the 45T3G and 276G3T genotypes on the basis of one-way analysis of covariance by using a general linear model followed by Bonferroni
test after adjustment for covariates such as age, sex, and BMI.
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healthy subjects. Moreover, significant correlations were ob-
served between plasma adiponectin and LDL particle size (r 
0.202, P 0.001) and serum triacylglycerol concentrations (r
0.308, P 0.001).
Relation of serum insulin and homeostasis model
assessment of insulin resistance to oxidative stress
Urinary excretion of PGF2 showed a highly significant pos-
itive relation with serum insulin (r  0.257, P  0.001) and
HOMA-IR (r 0.239, P 0.001) in healthy subjects. However,
we did not find a significant correlation between plasma adi-
ponectin concentrations and the urinary excretion of PGF2.
Relation between SNP 276G3T and adiponectin
concentrations and homeostasis model assessment of
insulin resistance according to BMI tertiles
We found a significantly positive correlation between
HOMA-IR and BMI (r  0.462, P  0.001) and significant
negative correlations between plasma adiponectin concentration
and HOMA-IR (r0.248, P 0.001) and BMI (r0.248,
P0.001). In addition, we observed an interaction between BMI
and genotype at position 276 for HOMA-IR (P  0.001) and
plasma adiponectin concentration (P  0.001). Therefore, we
performed a subset analysis by dividing the subjects into sub-
groups according to BMI tertiles. As shown in Figure 2, there
were no significant differences in HOMA-IR and plasma adi-
ponectin concentrations between the SNP 276G3T genotypes
in the lean (BMI  23.2) and the intermediate (23.2  BMI 
26.0) subgroups. However, in the obese subgroup (BMI 26.0),
we observed significant differences in HOMA-IR (G/G: 2.68
0.11; G/T: 2.60  0.19; T/T: 1.89  0.15; P  0.011) and
adiponectin concentrations (G/G: 5.390.25; G/T: 5.740.30;
T/T: 7.08  0.62 g/mL; P  0.026) according to the SNP
276G3T genotypes. We also found a significant (P  0.001)
interaction between BMI and the 45/276 haplotype for plasma
adiponectin concentrations. Significant differences in adiponec-
tin concentrations (TG/TG: 6.11 0.30; G/T: 6.06 0.18; T/T:
7.16  0.24 g/mL; P  0.020) were observed only in the
subjects in the highest BMI tertile. However, the ACDC 45T3G
genotypes were not associated with HOMA-IR and plasma adi-
ponectin concentrations according to the BMI tertiles (data not
shown).
FIGURE 1. Serum triacylglycerol and small dense LDL (LDL3) concentrations according to ACDC 45T3G and 276G3T in healthy subjects. Means with
different superscript letters in SNP 45 or 276 are significantly different, P  0.05 (one-way analysis of covariance with a general linear model followed by
Bonferroni test after adjustment for covariates such as age, sex, and BMI).
TABLE 3
Serum lipid profiles, LDL subfractions, and LDL particle size according to the ACDC 45T3G and 276G3T genotypes in healthy Koreans1
SNP 45T3G SNP 276G3T
T/T
(n 443)
T/G
(n 386)
G/G
(n 73)
G/G
(n 451)
G/T
(n 376)
T/T
(n 75)
Total cholesterol (mg/dL) 198.4 1.74 200.6 1.96 197.9 4.58 200.7 1.71 198.9 2.04 193.4 4.21
LDL cholesterol (mg/dL) 124.9 1.58 126.1 1.75 122.4 4.01 125.7 1.54 125.1 1.80 122.9 4.21
HDL cholesterol (mg/dL) 47.3 0.58 47.1 0.59 46.6 1.27 46.7 0.51 47.6 0.61 48.0 1.82
Apo A1 (mg/dL) 138.7 1.16 139.4 1.34 140.7 2.62 139.2 1.16 139.4 1.29 138.0 3.13
Apo B (mg/dL) 87.3 1.28 87.8 1.39 85.3 3.17 87.7 1.25 87.3 1.46 85.8 2.91
LDL1 (%) 17.1 1.21 15.4 1.64 13.6 7.9 14.2 1.53 16.8 1.34 20.8 3.10
LDL2 (%) 55.3 2.03 50.6 3.28 47.5 8.56 50.9 3.04b 51.6 2.32b 65.4 2.93a
LDL3 (%) 27.6 2.37 34.0 4.03 39.0 11.1 34.9 3.57a 31.6 2.97a 14.0 1.11b
LDL particle size (nm) 25.6 0.05 25.7 0.06 25.7 0.13 25.6 0.05b 25.6 0.06b 25.9 0.11a
1 All values are x  SE. SNP, single-nucleotide polymorphism; Apo, apolipoprotein. Values in the same row with different superscript letters are
significantly different, P 0.05 (one-way analysis of covariance by using a general linear model followed by Bonferroni test after adjustment for covariates
such as age, sex, and BMI).
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DISCUSSION
The current study shows a significant association between
ACDC 276G3T genotypes and adiponectin concentrations and
HOMA-IR in healthy Korean subjects after adjustment for po-
tential confounders, including age, sex, and BMI. These findings
are consistent with a previous report (8) showing that ACDC
276G3T genotypes were associated with IR, which could be
mediated through alterations on the expression level that subse-
quently affected plasma adiponectin concentrations. It is inter-
esting that we observed in the current study that these effects
were significant only in the population-specific highest tertile of
BMI (BMI26).
The current results suggest that the genotype effects of the
adiponectin gene on circulating adiponectin and IR are more
significant in overweight or obese subjects than in lean subjects.
Similarly, Hara et al (8) found that the G allele at position 276 was
linearly associated with lower plasma adiponectin concentra-
tions only in subjects in the highest BMI tertile (BMI 26.7). It
should be noted that this observation within the ACDC locus, by
which the phenotypic expression of the genotype is observed
primarily among subjects with elevated BMI or other measures
of obesity. is consistent with observations from many other CVD
candidate genes (26, 27). Reports have shown that low circulat-
ing adiponectin concentrations predicted the risk of developing
IR or type 2 diabetes in small Pima Indian cohorts (28, 29) and in
a larger and genetically heterogeneous white cohort (30, 31). It
has been suggested that IR is a consequence rather than a pre-
dictor of decreased adiponectin expression in adipose tissue (8).
Urinary excretion of PGF2, a sensitive marker of oxidative
stress (32), was observed to be high under conditions that pre-
dispose to CAD, such as IR, hypertension, and hypercholester-
olemia (33, 34). In fact, most CAD risk factors, including those
involved in the metabolic syndrome, are known to be closely
associated with IR. Therefore, the association between the
ACDC 276G3T polymorphism and IR might provide the basis
for the observed association between the presence of the G allele
and higher urinary excretion of PGF2.
An important and novel contribution from this study relates to
the identified association between the ACDC 276G3T poly-
morphism and small dense LDL (LDL3) and LDL particle size,
both of which are considered CAD risk factors (35). In the current
study, carriers of the G allele at ACDC 276G3T had signifi-
cantly higher mean LDL3 concentrations and smaller LDL par-
ticle size than did subjects with the T/T genotype, which poten-
tially places the former group of subjects at a significantly higher
risk of CAD (22).
High LDL3 concentrations have been associated with visceral
fat accumulation (36) and a carbohydrate-rich diet in Koreans
(37). However, in the current study, we did not observe signifi-
cant differences in abdominal body fat areas and usual carbohy-
drate intakes between genotype groups for SNP 276G3T. A
strong independent association between small LDL particle size
FIGURE 2. Effects of the SNP 276 genotype on homeostasis model
assessment of insulin resistance [HOMA-IR [fasting insulin (IU/mL)
fasting glucose (mmol/L)]/22.5] and plasma adiponectin concentrations in
healthy subjects. Means with different superscript letters in SNP 45 or 276 are
significantly different, P 0.05 (analysis of covariance with a general linear
model followed by Bonferroni test after adjustment for covariates such as
age, sex, and BMI).
TABLE 4
Circulating glucose, insulin, adiponectin, and C-reactive protein (CRP) concentrations and urinary prostaglandin F2 (PGF2) concentrations according to
the ACDC 45T3G and 276G3T genotypes in healthy Koreans1
SNP 45T3G SNP 276G3T
T/T
(n 443)
T/G
(n 386)
G/G
(n 73)
G/G
(n 451)
G/T
(n 376)
T/T
(n 75)
Glucose (mg/dL) 84.4 0.52 85.9 0.63 85.2 1.28 85.3 0.53 85.2 0.63 83.4 1.24
Insulin (IU/mL) 9.19 0.31 9.67 0.37 8.43 0.45 9.49 0.29 9.45 0.40 7.91 0.42
HOMA-IR 1.92 0.07 2.06 0.08 1.77 0.10 2.01 0.06a 1.98 0.08a,b 1.65 0.10b
Adiponectin (g/mL) 6.40 0.18 6.41 0.22 6.89 0.39 6.22 0.17b 6.43 0.22a,b 7.67 0.41a
CRP (mg/dL) 0.15 0.01 0.19 0.02 0.18 0.03 0.17 0.01 0.17 0.01 0.18 0.03
PGF2 (pg/mg creatinine) 1030.9 44.1 1080.3 42.0 1243.6 129.5 1123.1 46.4a 1054.6 44.1a,b 838.1 61.8b
1 All values are x  SE. HOMA-IR, homeostasis model assessment of insulin resistance, calculated as [fasting insulin (IU/mL)  fasting glucose
(mmol/L)]/22.5. Values in the same row with different superscript letters are significantly different, P 0.05 (one-way analysis of covariance by using a general
linear model followed by Bonferroni test after adjustment for covariates such as age, sex, and BMI).
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and low adiponectin concentrations was observed (36, 38). In
addition, LDL3 concentrations and small LDL particle size were
reported to be associated with high fasting triacylglycerol con-
centrations (21) and high IR (39). Therefore, the high concen-
trations of LDL3 and small LDL particle size in G carriers might
be related to the high IR and triacylglycerol concentrations and
low circulating adiponectin that are associated with the genetic
variation at the adiponectin locus.
In the SNP 45 and 276 haplotype test, we observed that, com-
pared with TG/TG or TG/X haplotype groups, subjects with the
X/X haplotype (non-TG haplotype carriers) had significantly
higher concentrations of plasma adiponectin after adjustment for
age, sex and BMI, but there were no significant haplotype effects
on HOMA-IR. In addition, we found that carriers of the X/X
haplotype in the highest BMI tertile group had significantly
higher adiponectin concentrations, which were similar to those
shown in SNP 276G3T. However, we did not observe any
significant genotype-related associations between ACDC
45T3G genotypes and circulating adiponectin and IR concen-
trations.
This finding is similar to the findings of previous studies by
Bacci et al (11). According to that report, SNP 276 was strongly
associated with CAD risk and IR, and the association was also
shown in the haplotype of SNPs 45 and 276. However, SNP 45
alone did not have any significant association. Menzaghi et al (7)
also found a similar association between both SNPs and
HOMA-IR in nondiabetic white subjects, but the strongest asso-
ciation was with a haplotype defined by both ACDC 45T3G and
276G3T. Considering these results, we assumed that the asso-
ciation with the 45/276 haplotype is due to the fact that SNP 45
is in strong linkage disequilibrium with SNP276. Therefore, SNP
276 polymorphism might be a better predictor of CVD risk than
is SNP 45 polymorphism. On the other hand, ACDC 45T3G
was significantly associated with obesity and insulin sensitivity
in a German population without a family history of diabetes (12).
Possible explanations for this discrepancy include differences in
family history status and anthropometric and ethnic factors.
In summary, the association of SNP 276 genotypes of the
adiponectin gene with circulating adiponectin concentrations
and HOMA-IR was clearly established in the current study in
healthy Korean subjects. In particular, the G allele at SNP 276
was associated with lower plasma adiponectin and higher IR in
relatively obese persons but not in lean persons. We showed that,
independent of other measured environmental factors, carriers of
the G allele at position 276 might be at high CVD risk because of
higher fasting triacylglycerol, small dense LDL concentrations,
oxidative stress, and smaller LDL particle size. Therefore, we
could suggest that this genetic marker may help in the identifi-
cation of subjects who are at greater risk of CVD risk, so that
preventive programs to reduce CVD in later life could be spe-
cifically targeted at these subjects.
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